A new Ottawa centre to conduct stem cell and gene therapy research has received commitments of more than $35 million from a variety of funding sources, helping to build critical mass in the city’s burgeoning health research sector.
Article Type: Generic
Quebec luring foreign and returning professors with five-year tax exemption
The Quebec government has extended its increasingly popular tax exemption legislation for foreign workers to the university sector, offering a five-year tax holiday to applicable professors in several key technology areas.
Top 100 R&D Spenders re-launched and expanded
Canada’s Top 100 Corporate R&D Spenders listing is back. After a hiatus of one year, the popular table and analysis of Canada’s biggest R&D spenders is now being prepared for publication in June. In addition to the listing, an in-depth report on Canadian R&D trends will also be available at the same time.
MEDICAL BRIEFS
Molecular Templates receives $1.5M in seed funding
Milestone Medica Corp, Sunnybrook Working Ventures Medical Breakthrough Fund and a private UK-based investor have banded together to finance and launch Molecular Templates Inc (MTI), an applied proteomics spin-off based on the work of Dr Jean Gariépy.
NSERC introduces dramatic new measures to increase flexibility and improve linkages to innovation
Canada’s largest research granting agency is forging ahead with a series of new initiatives that mark a major overhaul of the 22-year-old organization, moving it further than ever into the cycle of innovation.
Determining the centre of decision-making power for science and technology initiatives spurs growing debate in Ottawa
Demand for new innovation-related spending is sparking debate over the central role apparently assumed by the Finance department in the process of selecting and promoting new science and technology (S&T) initiatives.
RE$EARCH MONEY Analysis: Science and technology proposals and requests for additional funding left hanging in absence of normal Budget cycle
This week’s Speech from the Throne will likely continue with the good news that the Liberal administration is firmly behind building Canada’s knowledge-based economy (KBE) but it’s unlikely to provide much comfort or direction to those expecting announcements through the normal Budget cycle.
GlaxoSmithKline’s Canadian operations possess formidable R&D strengths that could increase in wake of recent merger
The Canadian arm of the newly merged GlaxoSmithKline plc is hoping that the combination of the two companies will create a powerful lure for attracting new corporate funding into its growing R&D operations and expanding partnerships with universities, the biotechnology sector and the Canadian Institutes of Health Research (CIHR).
Nortel Networks R&D breaks Cdn$6 billion
Nortel Networks Corp has increased its grip as Canada’s dominant corporate R&D spender with explosive new data contained in its year-end results. For FY00 ending December 31, the Mississauga ON-based telecommunications giant racked up Cdn$6.
Health Canada becomes first department to create position of chief scientist with appointment of Dr Kevin Keough
Health Canada has taken the lead in implementing a key plank of the 1999 SAGE report with the appointment of Dr Kevin Keough as its chief scientist. Keough, Memorial Univ’s VP research and international relations, will take up the newly created post April 2 by taking a three-year executive interchange that could stretch to five years.